Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03861078 · ClinicalTrials.gov registry record · NA
The Effect of Electronic Cigarette Liquid Characteristics in Smokers.
A NA study of Electronic Cigarettes, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
- 1
- Study location
NCT03861078: Completed NA study of Electronic Cigarettes, sponsored by Virginia Commonwealth University.
NCT03861078 is a NA study of Electronic Cigarettes that has completed, run by Virginia Commonwealth University. The registered enrollment target is 22 participants, below the 42-participant average among 3 other Electronic Cigarettes trials with a reported enrollment target (48% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03861078, a NA study of Electronic Cigarettes, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine differences in nicotine delivery, user behaviors, subjective effects, and physiological effects, when cigarette smokers use an electronic cigarette with different nicotine (and sweetener) concentrations relative to using their own brand of cigarettes.
Primary Outcome
Change in plasma nicotine concentration. Changes in plasm nicotine concentration during puff bout are considered to be the more relevant and accurate values so analysis and results reporting will focus on change from baseline to immediately following 10-puff bout.
Conditions Studied
Interventions
- OTHER Own Brand Cigarette
- OTHER ECIG 15 mg nicotine, sweetened
- OTHER ECIG 15 mg nicotine, unsweet
- OTHER ECIG 0 mg nicotine, sweetened
- OTHER ECIG 0 mg nicotine, unsweet
Study Locations (1)
Virginia
- Clinical Behavioral Pharmacology Laboratory - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2020-02-17 |
| Est. Completion | 2021-12-13 |
| Phase | NA |
What the finished NCT03861078 record still lists
NCT03861078 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 42-participant average among 3 other Electronic Cigarettes trials with a reported enrollment target (48% lower).
The record links to 1 condition, with Electronic Cigarettes appearing as the primary indexed condition, and to 5 interventions - of which Own Brand Cigarette is the first listed.
NCT03861078 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT03861078 about?
NCT03861078 is a clinical study titled "The Effect of Electronic Cigarette Liquid Characteristics in Smokers.". The purpose of this study is to determine differences in nicotine delivery, user behaviors, subjective effects, and physiological effects, when cigarette smokers use an electronic cigarette with different nicotine (and sweetener) concentrations relative to using their own brand of cigarettes.
What is the current status of trial NCT03861078?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2020-02-17. Estimated completion is 2021-12-13.
What conditions does trial NCT03861078 study?
This clinical trial studies the following conditions: Electronic Cigarettes.
What interventions are being tested in trial NCT03861078?
The interventions under investigation include: Own Brand Cigarette (OTHER), ECIG 15 mg nicotine, sweetened (OTHER), ECIG 15 mg nicotine, unsweet (OTHER), ECIG 0 mg nicotine, sweetened (OTHER), ECIG 0 mg nicotine, unsweet (OTHER).
Who is sponsoring clinical trial NCT03861078?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03861078 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Electronic Cigarettes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI